Adamis Pharmaceuticals

- NASDAQ:ADMP
Last Updated 2021-07-30
  • Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
  • Locations

    • San Diego CA
  • Total Funding (USD)

    15.8 million
  • Industries

    Software, Mobile Apps, Real Estate, Cyber Security, Internet
  • Acquisitions (2)

    • US Compounding (2016)
    • Cellegy Pharmaceuticals (2008)
  • Security

    Type: ORD
    CUSIP: 00547W208
    ISIN: US00547W2089
Filter date
All
Bookmark Created by Last updated
There were no results found.
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.